Current Strategies for Therapeutic Drug Delivery After Traumatic CNS Injury
- 17 April 2019
- journal article
- review article
- Published by Taylor & Francis in Therapeutic Delivery
- Vol. 10 (4) , 251-263
Abstract
Therapeutic strategies for traumatic injuries in the central nervous system (CNS) are largely limited to the efficiency of drug delivery. Despite the disrupted blood–CNS barrier during the early phase after injury, the drug administration faces a variety of obstacles derived from homeostatic imbalance at the injury site. In the late phase after CNS injury, the restoration of the blood–CNS barrier integrity varies depending on the injury severity resulting in inconsistent delivery of therapeutics. This review intends to characterize those different challenges of the therapeutic delivery in acute and chronic phases after injury and discuss recent advances in various approaches to explore novel strategies for the treatment of traumatic CNS injury.Keywords
This publication has 80 references indexed in Scilit:
- Challenges and New Strategies for Therapeutic Peptide Delivery to the CNSTherapeutic Delivery, 2015
- Blood–brain barrier dysfunction following traumatic brain injuryMetabolic Brain Disease, 2015
- Blood-neural barrier: Overview and latest progressClinical and Experimental Neuroimmunology, 2013
- Hemorrhagic Progression of a Contusion after Traumatic Brain Injury: A ReviewJournal of Neurotrauma, 2012
- Blood–Brain Barrier Pathophysiology in Traumatic Brain InjuryTranslational Stroke Research, 2011
- The blood–spinal cord barrier: Morphology and Clinical ImplicationsAnnals of Neurology, 2011
- Characteristics of compounds that cross the blood-brain barrierBMC Neurology, 2009
- Degenerative and regenerative mechanisms governing spinal cord injuryNeurobiology of Disease, 2004
- Edema and brain traumaNeuroscience, 2004
- Temporal–Spatial Pattern of Acute Neuronal and Glial Loss after Spinal Cord ContusionExperimental Neurology, 2001